-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AblT7u2/Fu8A1xvw08eKRyFq5v7VBwUpaRISFc5uC1gAyRFCrzCmP0H4qkPPSOYn 4I8iuZbAK06+ODrsIMR/dA== 0000950142-05-000473.txt : 20050217 0000950142-05-000473.hdr.sgml : 20050217 20050217193437 ACCESSION NUMBER: 0000950142-05-000473 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050215 FILED AS OF DATE: 20050217 DATE AS OF CHANGE: 20050217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARRIER THERAPEUTICS INC CENTRAL INDEX KEY: 0001173657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223828030 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 COLLEGE ROAD EAST STREET 2: SUITE 3200 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099451200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS FUND MANAGEMENT LLC CENTRAL INDEX KEY: 0001029160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625475 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2128721054 MAIL ADDRESS: STREET 1: C/O AKIN, GUMP, STRAUSS,HAUER,FELD, STREET 2: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEARL FRANK H CENTRAL INDEX KEY: 0000927752 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625476 BUSINESS ADDRESS: STREET 1: 2099 PENNSYLVANIA AVENUE NW STREET 2: SUITE 900 CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: 2024520101 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVENUE NW STREET 2: SUITE 900 CITY: WASHINGTON STATE: DC ZIP: 20003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SFM PARTICIPATION LP CENTRAL INDEX KEY: 0001253598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625479 MAIL ADDRESS: STREET 1: C/O SOROS FUND MANAGEMENT LLC STREET 2: 888 SEVENTH AVE 31ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS BIOTECH FUND PARTNERS LLC CENTRAL INDEX KEY: 0001250198 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625480 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS SOROS PARTNERS LLC CENTRAL INDEX KEY: 0001250191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625481 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 29TH FL CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUS SOROS BIOPHARMACEUTICAL FUND LP CENTRAL INDEX KEY: 0001111408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625482 BUSINESS ADDRESS: STREET 1: ARMY & NAVY CLUB BLDG STREET 2: 1627 I ST NW STE 610 CITY: WASHINGTON STATE: DC ZIP: 20006 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 29TH FL CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS GEORGE CENTRAL INDEX KEY: 0000900203 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625474 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-262--6 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 33RD FLR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SFM AH LLC CENTRAL INDEX KEY: 0001237655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625478 BUSINESS ADDRESS: STREET 1: C/O SOROS FUND MANAGEMENT LLC STREET 2: 888 SEVENTH AVENUE 31ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2122626300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUSPUR LLC CENTRAL INDEX KEY: 0001253323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50680 FILM NUMBER: 05625477 BUSINESS ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 4 1 form4-psbpf021505_btrxex.xml FORM 4 X0202 4 2005-02-15 1 0001173657 BARRIER THERAPEUTICS INC BTRX 0001111408 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP 888 SEVENTH AVENUE 29TH FL NEW YORK NY 10106 0 0 0 1 See footnote (2) 0001250191 PERSEUS SOROS PARTNERS LLC 888 SEVENTH AVENUE 29TH FL NEW YORK NY 10106 0 0 0 1 See footnote (2) 0001250198 PERSEUS BIOTECH FUND PARTNERS LLC 2099 PENNSYLVANIA AVE NW STE 900 WASHINGTON DC 20006-1813 0 0 0 1 See footnote (2) 0001253598 SFM PARTICIPATION LP C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVE 31ST FL NEW YORK NY 10106 0 0 0 1 See footnote (2) 0001237655 SFM AH LLC C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 31ST FLOOR NEW YORK NY 10106 0 0 0 1 See footnote (2) 0001253323 PERSEUSPUR LLC 2099 PENNSYLVANIA AVE NW STE 900 WASHINGTON DC 20006-1813 0 0 0 1 See footnote (2) 0000927752 PEARL FRANK H 2099 PENNSYLVANIA AVENUE NW SUITE 900 WASHINGTON DC 20006 0 0 0 1 See footnote (2) 0001029160 SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 0 1 See footnote (2) 0000900203 SOROS GEORGE 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 0 1 See footnote (2) Common Stock, par value $.0001 per share ("Common Stock") 2005-02-15 4 S 0 430004 19.50 D 2324734 D All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"). Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseuspur, LLC, a Delaware limited liability company ("Perseuspur") is the managing member of Perseus Partners. Mr. Frank H. Pearl is the sole member of Perseuspur. SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. Soros Fund Management LLC ("SFM LLC") is the managing member of SFM AH. Mr. George Soros is the Chairman of SFM LLC. (2) The Reporting Persons are no longer subject to Section 16. (3) Ms. Anzalotta is signing in her capacity as Ass't. General Counsel of SFM LLC, as Managing Member of SFM AH LLC, as General Partner of SFM Participation, as Managing Member of Perseus Soros Partners, as General Partner of Perseus-Soros. (4) Ms. Anzalotta is signing in her capacity as Ass't. General Counsel of SFM LLC, as Managing Member of SFM AH LLC, as General Partner of SFM Participation, as Managing Member of Perseus-Soros Partners. (5) Mr. Macklin is signing in his capacity as Secretary and Treasurer of Perseuspur, as Managing Member of Perseus Partners. (6) Ms. Anzalotta is signing in her capacity as Ass't. General Counsel of SFM LLC, as Managing Member of SFM AH LLC, as General Partner of SFM Participation. (7) Ms. Anzalotta is signing in her capacity as Ass't. General Counsel of SFM LLC, as Managing Member of SFM AH LLC. (8) Mr. Macklin is signing in his capacity as Attorney-in-Fact for Mr. Pearl. (9) Ms. Anzalotta is signing in her capacity as Ass't. General Counsel of SFM LLC. (10) Ms. Anzalotta is signing in her capacity as Attorney-in-Fact for Mr. Soros. Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), Perseus-Soros Partners, Perseus Partners, SFM Participation, Perseuspur, SFM AH, Mr. Pearl, SFM LLC and Mr. Soros are deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of Perseus-Soros. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that Perseus-Soros Partners, Perseus Partners, SFM Participation, Perseuspur, SFM AH, Mr. Pearl, SFM LLC or Mr. Soros is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros in excess of such amount. /s/ Jodye M. Anzalotta, Perseus-Soros BioPharmaceutical Fund, LP (3) 2005-02-17 /s/ Jodye M. Anzalotta, Perseus-Soros Partners, LLC (4) 2005-02-17 /s/ Rodd Macklin, Perseus Biotech Fund Partners, LLC (5) 2005-02-17 /s/ Jodye M. Anzalotta, SFM Participation, L.P. (6) 2005-02-17 /s/ Jodye M. Anzalotta, SFM AH LLC (7) 2005-02-17 /s/ Rodd Macklin, Perseuspur, LLC 2005-02-17 /s/ Rodd Macklin, Attorney-in-Fact for Frank H. Pearl (8) 2005-02-17 /s/ Jodye M. Anzalotta, Soros Fund Management LLC (9) 2005-02-17 /s/ Jodye M. Anzalotta, Attorney-in-Fact for George Soros (10) 2005-02-17 -----END PRIVACY-ENHANCED MESSAGE-----